Rosalind Advisors »

Ovid Therapeutics shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5M 1.1M 2.22
2025-06-30 $165k 500k 0.33

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Xeris Pharmaceuticals (XERS)
Fennec Pharmaceuticals (FENC)
Savara (SVRA)
Vaxcyte (PCVX)
Eyepoint Pharmaceuticals Com New (EYPT)
X4 Pharmaceuticals Com New (XFOR)
Vor Biopharma Com New (VOR)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Cybin Com New (HELP)
Cg Oncology (CGON)
Inspiremd (NSPR)

View all positions for Rosalind Advisors

Top funds holding Ovid Therapeutics

RA Capital Management
Henderson Group
Affinity Asset Advisors
Eventide Asset Management
Adage Capital Partners GP
Balyasny Asset Management
Vanguard Capital Management
ADAR1 Capital Management
Saturn V Capital Management
Federated Investors
Ikarian Capital
Ally Bridge Group
Susquehanna International
Blue Owl Capital Holdings
Sphera Funds Management

View all funds holding Ovid Therapeutics